Evidence map›Paper›PMID 31796767›Full record

ArticleScientific reports2019

Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.

Wolfgang Rudolf Bauer, Dennis H Lau, Christian Wollmann, Andrew McGavigan, Jacques Mansourati, Theresa Reiter, Simone Frömer, Mark E Ladd, Harald H Quick

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wolfgang Rudolf BauerDepartment of Internal Medicine I, Universitätsklinikum Würzburg, Würzburg, Germany. bauer_w@ukw.de.
Dennis H LauCentre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.ORCID http://orcid.org/0000-0001-7753-1318
Christian WollmannDepartment of Internal Medicine III, Universitätsklinikum St. Pölten, St. Pölten, Austria.
Andrew McGaviganFlinders Medical Centre, Bedford Park, Australia.
Jacques MansouratiHôpital de la Cavale Blanche, University Hospital of Brest and University of Western Brittany, Brest, France.
Theresa ReiterDepartment of Internal Medicine I, Universitätsklinikum Würzburg, Würzburg, Germany.
Simone FrömerCentre for Clinical Research, BIOTRONIK SE & Co. KG, Berlin, Germany.
Mark E LaddMedical Physics in Radiology, German Cancer Research Center, Heidelberg, Germany.
Harald H QuickHigh-Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Magnetic resonance imaging (MRI) has long been contraindicated in patients with implanted pacemakers, defibrillators, and cardiac resynchronisation therapy (CRT) devices due to the risk of adverse effects through electromagnetic interference. Since many recipients of these devices will have a lifetime indication for an MRI scan, the implantable systems should be developed as 'MRI-conditional' (be safe for the MRI environment under predefined conditions). We evaluated the clinical safety of several Biotronik ProMRI ('MRI-conditional') defibrillator and CRT systems during head and lower lumbar MRI scans at 1.5 Tesla. The study enrolled 194 patients at 22 sites in Australia, Canada, and Europe. At ≥9 weeks after device implantation, predefined, non-diagnostic, specific absorption rate (SAR)-intensive head and lower lumbar MRI scans (total ≈30 minutes per patient) were performed in 146 patients that fulfilled pre-procedure criteria. Three primary endpoints were evaluated: freedom from serious adverse device effects (SADEs) related to MRI and defibrillator/CRT (leading to death, hospitalisation, life-threatening condition, or potentially requiring implanted system revision or replacement), pacing threshold increase, and sensing amplitude decrease, all at the 1-month post-MRI clinical visit. No MRI-related SADE occurred. Lead values remained stable, measured in clinic and monitored daily by the manufacturer home monitoring technology.

Indexed as

Defibrillators, ImplantableFemaleHeadHumansLumbosacral RegionMagnetic Resonance ImagingMaleMiddle AgedPatient SafetyProspective Studies

Identifiers

PMID31796767
PMCPMC6890633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.